Search Ontology:
ChEBI

beta-D-Galp-(1->4)-beta-D-Glcp-(1->3)-D-GalpNAc

Term ID
CHEBI:147089
Synonyms
  • beta-D-galacto-hexopyranosyl-(1->4)-beta-D-gluco-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-D-galacto-hexopyranose
  • beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->3)-2-acetamido-2-deoxy-D-galactopyranose
  • Gal(b1-4)Glc(b1-3)GalNAc
  • N-[(3R,4R,5R,6R)-4-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
Definition
An amino trisaccharide consisting of β-D-galactopyranose, β-D-glucopyranose and 2-acetamido-2-deoxy-D-galactopyranose residues joined in sequence by (1→4) and (1→3) glycosidic bonds.
References
  • glygen:G10149FE
  • glytoucan:G10149FE
  • kegg.glycan:G08389
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from beta-D-Galp-(1->4)-beta-D-Glcp-(1->3)-D-GalpNAc
Phenotype where environments contain beta-D-Galp-(1->4)-beta-D-Glcp-(1->3)-D-GalpNAc
Phenotype modified by environments containing beta-D-Galp-(1->4)-beta-D-Glcp-(1->3)-D-GalpNAc
Phenotype affecting beta-D-Galp-(1->4)-beta-D-Glcp-(1->3)-D-GalpNAc
Human Disease Model